Year: 2020

CARLSBAD, Calif., Dec. 28, 2020 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced that its management will present at the upcoming J.P. Morgan 39th Annual Healthcare Conference on Wednesday, January 13, 2021 at 10:00 a.m. Eastern Time.A live, audio-only webcast of the presentation may be accessed by visiting ir.acutusmedical.com. A replay of the webcast will be available shortly after the conclusion of the presentation and will be archived on the Company’s website for 30 days following the presentation.About Acutus Medical, Inc.Acutus Medical is an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated. Acutus is committed to advancing...

SHENZHEN, China, Dec. 28, 2020 (GLOBE NEWSWIRE) — Meten EdtechX Education Group Ltd. (Nasdaq: METX) (“Meten EdtechX” or the “Company”), a leading omnichannel English language training (“ELT”) service provider in China, today announced that it has waived a condition to its previously announced offer to exercise (“Offer to Exercise”) certain warrants (the “Warrants”) at a reduced price of $1.40 per share. The Company has waived the condition requiring that at least sixty-five percent (65%) of the outstanding Warrants be tendered prior to 11:59 p.m. (Eastern Time) on January 5, 2021 (the “Expiration Date”). In connection with the waiver, if the Company completes the offer, the exercise price of all outstanding Warrants following the Expiration Date will temporarily be reduced to $2.50 per share, and be subject to a “full-ratchet” anti-dilution...

CHICAGO, Dec. 28, 2020 (GLOBE NEWSWIRE) — Sprout Social, Inc. (“Sprout Social”, the “Company”) (Nasdaq: SPT), an industry-leading provider of cloud-based social media management software, today announced the promotion of Ryan Barretto to President, effective immediately. Barretto, previously Sprout Social’s Senior Vice President of Global Sales, will continue to report to Chairman and CEO, Justyn Howard.“I am grateful for this opportunity to help lead the next chapter in Sprout’s story,” said Ryan Barretto, President of Sprout Social, who will now oversee global sales, customer success and marketing. “I’ve been honored to be a part of Sprout’s growth over the past four years particularly because it’s been fueled by an equal commitment to both our employees’ and customers’ success. That foundation,...

NEW HAVEN, Conn., Dec. 28, 2020 (GLOBE NEWSWIRE) — Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation using its PROTAC® Discovery Engine, today announced that the underwriters of its previously announced underwritten public offering of common stock, which closed on December 18, 2020, have exercised in full their option to purchase additional shares of common stock at the public offering price, less underwriting discounts and commissions. After giving effect to the sale of 857,142 additional shares of common stock in the option closing, the total number of shares of common stock sold by Arvinas in the offering increased to 6,571,428 shares, which resulted in aggregate net proceeds of approximately $431.9 million.   All of the shares were offered...

OMAHA, Neb., Dec. 28, 2020 (GLOBE NEWSWIRE) — Green Plains Inc. (NASDAQ:GPRE) today announced that its subsidiary, Green Plains Hereford LLC, has completed the previously announced sale of its ethanol plant located in Hereford, Texas, to Hereford Ethanol Partners, L.P. for $39 million, plus working capital. Additionally, an earnout provision of up to $75 million related to certain value enhancement opportunities, including future earnings from Low Carbon Fuel Standard credits was included as part of the transaction. In conjunction with this transaction, Green Plains Partners LP (NASDAQ:GPP) today also announced it has completed the sale of the storage assets and the assignment of certain rail transportation assets associated with Green Plains Hereford LLC for $10 million. The proceeds from the transaction were used to repay debt.About...

NEW YORK, Dec. 28, 2020 (GLOBE NEWSWIRE) — Prospect Capital Corporation (the “Company”) today announced that it has commenced a cash tender offer (the “Tender Offer”) to purchase up to $20,000,000 aggregate principal amount of outstanding 6.375% Convertible Notes due 2025 (the “Notes”). The Tender Offer will expire at 12:00 midnight, New York City time, on January 27, 2021 (one minute after 11:59 p.m., New York City time, on January 26, 2021), or any other date and time to which the Company extends the Tender Offer (such date and time, as it may be extended, the “Expiration Date”). The Tender Offer is made pursuant to an Offer to Purchase dated today, which sets forth the terms and conditions of the Tender Offer.The consideration to be paid for each $1,000 principal amount of Notes that are validly tendered and not validly withdrawn...

SAN DIEGO, Dec. 28, 2020 (GLOBE NEWSWIRE) — Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a specialty health sciences company that develops clinically supported nutrition, medical foods and medical devices, with a focus in the ocular health marketplace, today announces the appointment of Bret Scholtes, a veteran of the nutritional products industry for nearly a decade, as its President and Chief Executive Officer, and as a member of the Board of Directors, commencing January 6, 2021.“We are delighted to welcome Bret to Guardion Health Sciences. We believe that his proven business acumen and extensive experience in the nutritional products industry will serve to usher Guardion into a new era of growth and success,” commented Robert Weingarten, Chairman of the Board of Guardion Health Sciences. “Bret’s...

FLORHAM PARK, N.J., Dec. 28, 2020 (GLOBE NEWSWIRE) — Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, today announced the closing of its previously announced underwritten public offering of its common stock for gross proceeds of approximately $24.5 million at a public offering price of $1.35 per share of common stock, prior to deducting underwriting discounts and commissions and estimated offering expenses.In a separate concurrent private placement transaction led by healthcare-focused institutional investors, Cellectar offered and sold 1,518.5180 shares of Series D convertible preferred stock convertible into a number of shares of common stock equal to $13,500 divided by $1.35 (or 10,000 shares...